MedTrace Logo

Evaluate the Predictive Impact of the MEESSI Score

NCT05340972 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2023-05-16

No results posted yet for this study

Summary

Our primary purpose is to assess MEESSI score in predicting mortality and readmission of patients managed for acute heart failure (AHF) in Emergency Department.

European Society of Cardiology recommend risk stratification for patients with AHF.

Conditions

  • Emergencies
  • Heart Diseases

Interventions

DIAGNOSTIC_TEST

MEESSI score

The score aimed to predict the AHF patient's future in the month following management for ED

Sponsors & Collaborators

  • University of Monastir

    lead OTHER

Principal Investigators

  • Semir Nouira, Pr · University of Monastir

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-15
Primary Completion
2023-05-30
Completion
2023-05-30

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05340972 on ClinicalTrials.gov